Skip to main content
Year archive

Galapagos NV — 2019 filings

All 324 regulatory filings released by Galapagos NV (GLPG) in 2019, sourced directly from the official regulator.

324 Filings
2019 Period
2019 filings (324)
Filing Released Lang
Gilead submits new drug application to U.S. Food and Drug Administration under priority review for filgotinib for rheumatoid arthritis treatment
Regulatory Filings
2019-12-20 Dutch
Gilead submits new drug application to U.S. Food and Drug Administration under priority review for filgotinib for rheumatoid arthritis treatment
Earnings Release FY 2019
2019-12-20 English
6-K Filing
Foreign Filer Report
2019-12-20 English
6-K Filing
Foreign Filer Report
2019-12-09 English
Galapagos completes recruitment of NOVESA trial in systemic sclerosis
Regulatory Filings
2019-12-06 Dutch
Galapagos completes recruitment of NOVESA trial in systemic sclerosis
Earnings Release Q4 2019
2019-12-06 English
Galapagos increases share capital through warrant exercises
Capital/Financing Update
2019-11-26 Dutch
Galapagos increases share capital through warrant exercises
Share Issue/Capital Change
2019-11-26 English
6-K Filing
Foreign Filer Report
2019-11-26 English
Share Capital Increase - 25-Nov-2019 - EN.pdf
Share Issue/Capital Change
2019-11-25 English
Share Capital Increase - 25-Nov-2019 - NL.docx.pdf
Share Issue/Capital Change
2019-11-25 Dutch
Galapagos receives transparency notification from Wellington Management Group LLP
Major Shareholding Notification
2019-11-19 Dutch
Galapagos receives transparency notification from Wellington Management Group LLP
Major Shareholding Notification
2019-11-19 English
6-K Filing
Foreign Filer Report
2019-11-19 English
Wellington TP 18 NOV_FINAL.docx.pdf
Major Shareholding Notification
2019-11-18 English
Wellington TP_18 nov NL FINAL.docx.pdf
Major Shareholding Notification
2019-11-18 Dutch
Transparency notification – Gilead holds 25.10% of Galapagos shares
Major Shareholding Notification
2019-11-14 English
Transparency notification – Gilead holds 25.10% of Galapagos shares
Major Shareholding Notification
2019-11-14 Dutch
6-K Filing
Foreign Filer Report
2019-11-14 English
Transparency PR GILD 25 FINAL.docx.pdf
Major Shareholding Notification
2019-11-13 English
Transparency PR GILD 25 NL FINAL.docx.pdf
Major Shareholding Notification
2019-11-13 Dutch
6-K Filing
Foreign Filer Report
2019-11-12 English
NEW DATA ON FILGOTINIB IN RHEUMATOID ARTHRITIS (RA) DEMONSTRATE DURABLE EFFICACY AND SAFETY PROFILE
AGM Information
2019-11-11 Dutch
NEW DATA ON FILGOTINIB IN RHEUMATOID ARTHRITIS (RA) DEMONSTRATE DURABLE EFFICACY AND SAFETY PROFILE
Earnings Release Q4 2019
2019-11-11 English
Galapagos increases share capital through warrant exercise by Gilead
Share Issue/Capital Change
2019-11-07 Dutch
Galapagos increases share capital through warrant exercise by Gilead
Share Issue/Capital Change
2019-11-07 English
PR Gilead warrant exercise FINAL.pdf
Declaration of Voting Results & Voting Rights Announcements
2019-11-06 English
PR Gilead warrant exercise NL FINAL.docx.pdf
Share Issue/Capital Change
2019-11-06 Dutch
6-K Filing
Foreign Filer Report
2019-11-06 English
Gilead delivers exercise notice to Galapagos for Initial Warrant A to increase ownership to 25.1%
Share Issue/Capital Change
2019-11-04 Dutch
Gilead delivers exercise notice to Galapagos for Initial Warrant A to increase ownership to 25.1%
Capital/Financing Update
2019-11-04 English
6-K Filing
Foreign Filer Report
2019-11-04 English
GILEAD AND GALAPAGOS TO PRESENT NEW DATA ON FILGOTINIB AT 2019 ACR/ARP ANNUAL MEETING
Regulatory Filings
2019-11-01 Dutch
Minutes extraordinary meeting Oct 2019.pdf
AGM Information
2019-10-30 English
Notulen buitengewone aandeelhoudersvergadering Okt 2019.pdf
AGM Information
2019-10-30 Dutch
MOR106 clinical development in atopic dermatitis stopped for futility
Regulatory Filings
2019-10-29 Dutch
6-K Filing
Foreign Filer Report
2019-10-29 English
Klinisch ontwikkelingsprogramma met MOR106 in eczeem gestopt voor futiliteit
Regulatory Filings
2019-10-28 English
Galapagos receives transparency notification from Wellington Management Group LLP
Major Shareholding Notification
2019-10-28 English
Galapagos receives transparency notification from Wellington Management Group LLP
Major Shareholding Notification
2019-10-28 English
6-K Filing
Foreign Filer Report
2019-10-28 English
Galapagos ontvangt transparantieverklaring van Wellington Management Group LLP
Major Shareholding Notification
2019-10-25 Dutch
Galapagos receives transparency notification from Wellington Management Group LLP
Major Shareholding Notification
2019-10-25 English
Wellington TP_22 okt NL FINAL.pdf
Major Shareholding Notification
2019-10-25 Dutch
Solid third quarter 2019 performance with strong balance sheet for continued R&D growth
Earnings Release 9M 2019
2019-10-25 Dutch
Solid third quarter 2019 performance with strong balance sheet for continued R&D growth
Earnings Release 9M 2019
2019-10-25 Dutch
6-K Filing
Foreign Filer Report
2019-10-25 English
Sterk derde kwartaal 2019 met solide balans voor verdere R&D-groei
Earnings Release 9M 2019
2019-10-24 Dutch
Solid third quarter 2019 performance with strong balance sheet for continued R&D growth
Earnings Release 9M 2019
2019-10-24 English
Solid third quarter 2019 performance with strong balance sheet for continued R&D growth.pdf
Earnings Release 9M 2019
2019-10-24 English
Sterk derde kwartaal 2019 met solide balans voor verdere R&D-groei.pdf
Interim / Quarterly Report 9M 2019
2019-10-24 Dutch
Q3 report 2019.pdf
Interim / Quarterly Report 9M 2019
2019-10-24 English
Q3 verslag 2019.pdf
Interim / Quarterly Report 9M 2019
2019-10-24 Dutch
6-K Filing
Foreign Filer Report
2019-10-23 English
GILEAD AND GALAPAGOS ANNOUNCE EFFICACY AND SAFETY RESULTS OF FILGOTINIB THROUGH 52 WEEKS IN FINCH 1 AND FINCH 3 STUDIES IN RHEUMATOID ARTHRITIS
Earnings Release Q4 2019
2019-10-11 Dutch
GILEAD AND GALAPAGOS ANNOUNCE EFFICACY AND SAFETY RESULTS OF FILGOTINIB THROUGH 52 WEEKS IN FINCH 1 AND FINCH 3 STUDIES IN RHEUMATOID ARTHRITIS
Legal Proceedings Report
2019-10-11 English
6-K Filing
Foreign Filer Report
2019-10-11 English
GILEAD EN GALAPAGOS KONDIGEN VEILIGHEIDS-EN WERKZAAMHEIDSRESULTATEN AAN OVER FILGOTINIB NA 52 WEKEN IN FINCH 1 EN 3 STUDIES IN REUMA
Earnings Release Q2 2019
2019-10-11 Dutch
GILEAD AND GALAPAGOS ANNOUNCE EFFICACY AND SAFETY RESULTS OF FILGOTINIB THROUGH 52 WEEKS IN FINCH 1 AND FINCH 3 STUDIES IN RHEUMATOID ARTHRITIS
Earnings Release FY 2019
2019-10-11 English
Galapagos receives transparency notification from Wellington Management Group LLP
Major Shareholding Notification
2019-10-08 English
Galapagos receives transparency notification from Wellington Management Group LLP
Major Shareholding Notification
2019-10-08 English
6-K Filing
Foreign Filer Report
2019-10-08 English
Galapagos ontvangt transparantieverklaring van Wellington Management Group LLP
Major Shareholding Notification
2019-10-07 Dutch
Galapagos receives transparency notification from Wellington Management Group LLP
Major Shareholding Notification
2019-10-07 English
Wellington TP FINAL.docx.pdf
Major Shareholding Notification
2019-10-07 English
Wellington TP_NL 4 okt 2019.docx.pdf
Major Shareholding Notification
2019-10-07 Dutch
Galapagos start Fase 1-studie met tweede Toledo-compound
Regulatory Filings
2019-09-25 English
Galapagos start Fase 1-studie met tweede Toledo-compound
Earnings Release Q3 2019
2019-09-25 Dutch
6-K Filing
Foreign Filer Report
2019-09-25 English
Galapagos start Fase 1-studie met tweede Toledo-compound
Regulatory Filings
2019-09-24 Dutch
Galapagos initiates Phase 1 trial for second Toledo compound
Regulatory Filings
2019-09-24 English
Galapagos initiates Phase 1 trial for second Toledo compound
Regulatory Filings
2019-09-24 English
Galapagos start Fase 1-studie met tweede Toledo-compound
Regulatory Filings
2019-09-24 Dutch
Galapagos start Fase 1-studie met tweede Toledo-compound
Regulatory Filings
2019-09-24 Dutch
Galapagos initiates Phase 1 trial for second Toledo compound
Regulatory Filings
2019-09-24 English
Galapagos start Fase 1-studie met tweede Toledo-compound
Regulatory Filings
2019-09-24 Dutch
Galapagos start Fase 1-studie met tweede Toledo-compound
Regulatory Filings
2019-09-24 Dutch
Galapagos initiates Phase 1 trial for second Toledo compound
Regulatory Filings
2019-09-24 English
Galapagos initiates Phase 1 trial for second Toledo compound
Regulatory Filings
2019-09-24 English
Invitation to the special and extraordinary shareholders' meetings
AGM Information
2019-09-23 English
Invitation to the special and extraordinary shareholders' meetings
AGM Information
2019-09-23 English
6-K Filing
Foreign Filer Report
2019-09-23 English
Invitation to the special and extraordinary shareholders' meetings
AGM Information
2019-09-20 English
Uitnodiging voor de bijzondere en buitengewone algemene vergaderingen
AGM Information
2019-09-20 Dutch
Uitnodiging voor de bijzondere en buitengewone algemene vergaderingen
AGM Information
2019-09-20 Dutch
Uitnodiging voor de bijzondere en buitengewone algemene vergaderingen
AGM Information
2019-09-20 Dutch
Uitnodiging voor de bijzondere en buitengewone algemene vergaderingen
AGM Information
2019-09-20 Dutch
Invitation to the special and extraordinary shareholders' meetings
AGM Information
2019-09-20 English
Invitation to the special and extraordinary shareholders' meetings
AGM Information
2019-09-20 English
Invitation to the special and extraordinary shareholders' meetings
AGM Information
2019-09-20 English
Invitation to the special and extraordinary shareholders' meetings
AGM Information
2019-09-20 English
Uitnodiging voor de bijzondere en buitengewone algemene vergaderingen
AGM Information
2019-09-20 Dutch
Uitnodiging voor de bijzondere en buitengewone algemene vergaderingen
AGM Information
2019-09-20 Dutch
Invitation to the special and extraordinary shareholders' meetings
AGM Information
2019-09-20 English
Uitnodiging voor de bijzondere en buitengewone algemene vergaderingen
AGM Information
2019-09-20 Dutch
Uitnodiging voor de bijzondere en buitengewone algemene vergaderingen
AGM Information
2019-09-20 Dutch
Uitnodiging voor de bijzondere en buitengewone algemene vergaderingen
AGM Information
2019-09-20 Dutch
Uitnodiging voor de bijzondere en buitengewone algemene vergaderingen
AGM Information
2019-09-20 Dutch
Invitation to the special and extraordinary shareholders' meetings
AGM Information
2019-09-20 English
3. Attendance Notification Form EN & NL.pdf
AGM Information
2019-09-20 Dutch
1. Convening Notice NL.pdf
AGM Information
2019-09-20 Dutch
6. Special Board report 583-596-598 NL.pdf
Share Issue/Capital Change
2019-09-20 Dutch
7. Auditor's report NL.pdf
Share Issue/Capital Change
2019-09-20 Dutch
2. Proxy Form EN & NL.pdf
Proxy Solicitation & Information Statement
2019-09-20 Dutch
9. Shares and Voting Rights EN & NL.pdf
Share Issue/Capital Change
2019-09-20 Dutch
8. Special Board report 604 NL.pdf
Capital/Financing Update
2019-09-20 Dutch
SGM EGM Notice PR (EN).pdf
AGM Information
2019-09-20 English
SGM EGM Notice PR (NL).pdf
AGM Information
2019-09-20 Dutch
Transparency notification
Major Shareholding Notification
2019-09-20 Dutch
Transparency notification
Declaration of Voting Results & Voting Rights Announcements
2019-09-20 English
Galapagos increases share capital through warrant exercises
Share Issue/Capital Change
2019-09-20 English
Galapagos increases share capital through warrant exercises
Capital/Financing Update
2019-09-20 Dutch
6-K Filing
Foreign Filer Report
2019-09-20 English
Transparantieverklaring
Major Shareholding Notification
2019-09-19 Dutch
Transparency notification
Major Shareholding Notification
2019-09-19 English
Transparency notification
Major Shareholding Notification
2019-09-19 English
Transparency notification
Major Shareholding Notification
2019-09-19 English
Transparency notification
Major Shareholding Notification
2019-09-19 English
Galapagos increases share capital through warrant exercises
Share Issue/Capital Change
2019-09-19 English
Galapagos increases share capital through warrant exercises
Share Issue/Capital Change
2019-09-19 English
Galapagos increases share capital through warrant exercises
Share Issue/Capital Change
2019-09-19 English
Transparantieverklaring
Major Shareholding Notification
2019-09-19 Dutch
Galapagos verhoogt kapitaal door uitoefening van warrants
Share Issue/Capital Change
2019-09-19 Dutch
Galapagos verhoogt kapitaal door uitoefening van warrants
Share Issue/Capital Change
2019-09-19 Dutch
Transparantieverklaring
Major Shareholding Notification
2019-09-19 Dutch
Transparantieverklaring
Major Shareholding Notification
2019-09-19 Dutch
Transparency notification
Major Shareholding Notification
2019-09-19 English
Galapagos verhoogt kapitaal door uitoefening van warrants
Share Issue/Capital Change
2019-09-19 Dutch
Galapagos verhoogt kapitaal door uitoefening van warrants
Share Issue/Capital Change
2019-09-19 Dutch
Galapagos increases share capital through warrant exercises
Share Issue/Capital Change
2019-09-19 English
Galapagos verhoogt kapitaal door uitoefening van warrants
Share Issue/Capital Change
2019-09-19 Dutch
Galapagos increases share capital through warrant exercises
Share Issue/Capital Change
2019-09-19 English
Transparantieverklaring
Major Shareholding Notification
2019-09-19 Dutch
Sands Capital TN Sep 2019_EN.pdf
Major Shareholding Notification
2019-09-19 English
Sands Capital TN Sep 2019_NL.pdf
Major Shareholding Notification
2019-09-19 Dutch
Share Capital Increase - 18-Sept-2019.pdf
Share Issue/Capital Change
2019-09-19 English
Kapitaalsverhoging- 18-Sept-2019 NL.pdf
Capital/Financing Update
2019-09-19 Dutch
6-K Filing
Foreign Filer Report
2019-09-19 English
6-K Filing
Foreign Filer Report
2019-09-05 English
6-K Filing
Foreign Filer Report
2019-09-05 English
Transparency notification
Major Shareholding Notification
2019-09-02 English
Transparency notification
Major Shareholding Notification
2019-09-02 Dutch
Transparantieverklaring
Major Shareholding Notification
2019-08-30 Dutch
Transparantieverklaring
Major Shareholding Notification
2019-08-30 Dutch
Transparantieverklaring
Major Shareholding Notification
2019-08-30 Dutch
Transparantieverklaring
Major Shareholding Notification
2019-08-30 Dutch
Transparency notification
Major Shareholding Notification
2019-08-30 English
Transparency notification
Major Shareholding Notification
2019-08-30 English
Transparency notification
Major Shareholding Notification
2019-08-30 English
Transparency notification
Major Shareholding Notification
2019-08-30 English
Transparantieverklaring
Major Shareholding Notification
2019-08-30 Dutch
Transparency notification
Major Shareholding Notification
2019-08-30 English
VANHERK 30 AUG 2019.pdf
Major Shareholding Notification
2019-08-30 English
VANHERK 30 AUG 2019_NL.pdf
Major Shareholding Notification
2019-08-30 Dutch
Transparantieverklaring – Gilead bezit 22% van de Galapagos aandelen
Declaration of Voting Results & Voting Rights Announcements
2019-08-29 English
Transparantieverklaring – Gilead bezit 22% van de Galapagos aandelen
Major Shareholding Notification
2019-08-29 Dutch
6-K Filing
Foreign Filer Report
2019-08-29 English
Transparency notification – Gilead holds 22% of Galapagos shares
Major Shareholding Notification
2019-08-28 English
Transparency notification – Gilead holds 22% of Galapagos shares
Major Shareholding Notification
2019-08-28 English
Transparantieverklaring – Gilead bezit 22% van de Galapagos aandelen
Major Shareholding Notification
2019-08-28 Dutch
Transparantieverklaring – Gilead bezit 22% van de Galapagos aandelen
Major Shareholding Notification
2019-08-28 Dutch
Transparency notification – Gilead holds 22% of Galapagos shares
Major Shareholding Notification
2019-08-28 English
Transparantieverklaring – Gilead bezit 22% van de Galapagos aandelen
Major Shareholding Notification
2019-08-28 Dutch
Transparantieverklaring – Gilead bezit 22% van de Galapagos aandelen
Major Shareholding Notification
2019-08-28 Dutch
Transparency notification – Gilead holds 22% of Galapagos shares
Major Shareholding Notification
2019-08-28 English
Transparency notification – Gilead holds 22% of Galapagos shares
Major Shareholding Notification
2019-08-28 English
Transparantieverklaring – Gilead bezit 22% van de Galapagos aandelen
Major Shareholding Notification
2019-08-28 Dutch
Transparency Notification PR (ENG) (268734.1).pdf
Major Shareholding Notification
2019-08-28 English
Transparency Notification PR (NL) 28082019.pdf
Declaration of Voting Results & Voting Rights Announcements
2019-08-28 Dutch
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
M&A Activity
2019-08-26 English
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
Capital/Financing Update
2019-08-26 English
Gilead en Galapagos ronden de closing van hun baanbrekende R&D-samenwerking af
Regulatory Filings
2019-08-23 Dutch
Gilead en Galapagos ronden de closing van hun baanbrekende R&D-samenwerking af
Regulatory Filings
2019-08-23 Dutch
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
Capital/Financing Update
2019-08-23 English
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
Capital/Financing Update
2019-08-23 English
Gilead en Galapagos ronden de closing van hun baanbrekende R&D-samenwerking af
Regulatory Filings
2019-08-23 Dutch
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
Capital/Financing Update
2019-08-23 English
Gilead en Galapagos ronden de closing van hun baanbrekende R&D-samenwerking af
Regulatory Filings
2019-08-23 Dutch
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
Capital/Financing Update
2019-08-23 English
Gilead en Galapagos ronden de closing van hun baanbrekende R&D-samenwerking af
Regulatory Filings
2019-08-23 Dutch
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
M&A Activity
2019-08-23 English
Closing FINAL.pdf
M&A Activity
2019-08-23 English
Closing NL FINAL.pdf
M&A Activity
2019-08-23 Dutch
O Galapagos - Rapport Project Eagle art 596 en 598 (ENG)-SignedbyDeloitte.pdf
Share Issue/Capital Change
2019-08-23 English
O Galapagos - Rapport Project Eagle art 596 en 598 (NL)-SignedbyDeloitte.pdf
Share Issue/Capital Change
2019-08-23 Dutch
Board Report 596-598 v1 (ENG)_website.pdf
Share Issue/Capital Change
2019-08-23 English
Board Report 596 598 (NL)_website.pdf
Capital/Financing Update
2019-08-23 Dutch
EUROPEAN MEDICINES AGENCY VALIDATES MARKETING APPLICATION FOR FILGOTINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
Legal Proceedings Report
2019-08-16 English
EUROPEES GENEESMIDDELENBUREAU VALIDEERT INDIENING VERGUNNINGSDOSSIER VOOR FILGOTINIB VOOR DE BEHANDELING VAN REUMATOÏDE ARTRITIS
Regulatory Filings
2019-08-15 Dutch
EUROPEES GENEESMIDDELENBUREAU VALIDEERT INDIENING VERGUNNINGSDOSSIER VOOR FILGOTINIB VOOR DE BEHANDELING VAN REUMATOÏDE ARTRITIS
Regulatory Filings
2019-08-15 Dutch
EUROPEES GENEESMIDDELENBUREAU VALIDEERT INDIENING VERGUNNINGSDOSSIER VOOR FILGOTINIB VOOR DE BEHANDELING VAN REUMATOÏDE ARTRITIS
Regulatory Filings
2019-08-15 Dutch
EUROPEES GENEESMIDDELENBUREAU VALIDEERT INDIENING VERGUNNINGSDOSSIER VOOR FILGOTINIB VOOR DE BEHANDELING VAN REUMATOÏDE ARTRITIS
Regulatory Filings
2019-08-15 Dutch
EUROPEAN MEDICINES AGENCY VALIDATES MARKETING APPLICATION FOR FILGOTINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
Regulatory Filings
2019-08-15 English
EUROPEAN MEDICINES AGENCY VALIDATES MARKETING APPLICATION FOR FILGOTINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
Regulatory Filings
2019-08-15 English
EUROPEAN MEDICINES AGENCY VALIDATES MARKETING APPLICATION FOR FILGOTINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
Regulatory Filings
2019-08-15 English
EUROPEAN MEDICINES AGENCY VALIDATES MARKETING APPLICATION FOR FILGOTINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
Regulatory Filings
2019-08-15 English
EUROPEES GENEESMIDDELENBUREAU VALIDEERT INDIENING VERGUNNINGSDOSSIER VOOR FILGOTINIB VOOR DE BEHANDELING VAN REUMATOÏDE ARTRITIS
Regulatory Filings
2019-08-15 Dutch
EUROPEAN MEDICINES AGENCY VALIDATES MARKETING APPLICATION FOR FILGOTINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
Regulatory Filings
2019-08-15 English
Strong clinical progress in H1 and transformative collaboration with Gilead announced
Earnings Release H1 2019
2019-07-26 English
Strong clinical progress in H1 and transformative collaboration with Gilead announced
Earnings Release H1 2019
2019-07-26 English
PR H1 2019_FINAL.pdf
Earnings Release H1 2019
2019-07-25 English
PR H1 2019_NL_FINAL.pdf
Earnings Release H1 2019
2019-07-25 Dutch
GLPG half year report 2019.pdf
Interim / Quarterly Report H1 2019
2019-07-25 English
GLPG halfjaarrapport 2019.pdf
Interim / Quarterly Report H1 2019
2019-07-25 Dutch
6-K Filing
Foreign Filer Report
2019-07-25 English
Transparency notification
Major Shareholding Notification
2019-07-19 English
Transparency notification
Major Shareholding Notification
2019-07-19 Dutch
6-K Filing
Foreign Filer Report
2019-07-19 English
VANHERK18 July2019.pdf
Major Shareholding Notification
2019-07-18 English
VANHERK 18 July2019_NL.pdf
Major Shareholding Notification
2019-07-18 Dutch
SC 13G/A Filing
Major Shareholding Notification
2019-07-17 English
GILEAD AND GALAPAGOS ENTER INTO TRANSFORMATIVE RESEARCH AND DEVELOPMENT COLLABORATION
M&A Activity
2019-07-15 English
GILEAD AND GALAPAGOS ENTER INTO TRANSFORMATIVE RESEARCH AND DEVELOPMENT COLLABORATION
Regulatory Filings
2019-07-15 English
6-K Filing
Foreign Filer Report
2019-07-15 English
GILEAD ANNOUNCES INTENT TO SUBMIT NEW DRUG APPLICATION FOR FILGOTINIB TO U.S. FOOD AND DRUG ADMINISTRATION THIS YEAR
Legal Proceedings Report
2019-07-02 Dutch
GILEAD ANNOUNCES INTENT TO SUBMIT NEW DRUG APPLICATION FOR FILGOTINIB TO U.S. FOOD AND DRUG ADMINISTRATION THIS YEAR
Regulatory Filings
2019-07-02 English
GILEAD ANNOUNCES INTENT TO SUBMIT NEW DRUG APPLICATION FOR FILGOTINIB TO U.S. FOOD AND DRUG ADMINISTRATION THIS YEAR
Regulatory Filings
2019-07-02 English
GILEAD KONDIGT PLAN AAN OM DIT JAAR EEN VERGUNNINGSDOSSIER VOOR FILGOTINIB IN TE DIENEN BIJ DE FDA
Legal Proceedings Report
2019-07-02 Dutch
6-K Filing
Foreign Filer Report
2019-07-02 English
Galapagos increases share capital through warrant exercises
Share Issue/Capital Change
2019-06-21 Dutch
Galapagos increases share capital through warrant exercises
Share Issue/Capital Change
2019-06-21 English
6-K Filing
Foreign Filer Report
2019-06-21 English
Share Capital Increase - 20-Jun-2019 - EN.pdf
Share Issue/Capital Change
2019-06-20 English
Share Capital Increase - 20-Jun-2019 - NL.pdf
Share Issue/Capital Change
2019-06-20 Dutch
Transparency notification
Major Shareholding Notification
2019-06-18 English
Transparency notification
Major Shareholding Notification
2019-06-18 Dutch
CAPITAL TP 14 June 2019_FINAL.pdf
Major Shareholding Notification
2019-06-17 English
CAPITAL TP 14 June 2019 NL_FINAL.pdf
Major Shareholding Notification
2019-06-17 Dutch
6-K Filing
Foreign Filer Report
2019-06-17 English
Servier and Galapagos complete enrollment of global ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients
Regulatory Filings
2019-06-11 English
Servier and Galapagos complete enrollment of global ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients
Regulatory Filings
2019-06-11 English
6-K Filing
Foreign Filer Report
2019-06-11 English
6-K Filing
Foreign Filer Report
2019-05-31 English
GILEAD AND GALAPAGOS TO PRESENT LATEST DATA ON FILGOTINIB AT THE ANNUAL EUROPEAN CONGRESS OF RHEUMATOLOGY (EULAR 2019)
Regulatory Filings
2019-05-30 Dutch
GILEAD AND GALAPAGOS TO PRESENT LATEST DATA ON FILGOTINIB AT THE ANNUAL EUROPEAN CONGRESS OF RHEUMATOLOGY (EULAR 2019)
Regulatory Filings
2019-05-30 English
S-8 Filing
Registration Form
2019-05-24 English
Minutes AGM 30 Apr 2019 - EN.pdf
AGM Information
2019-05-16 English
AGM 30 Apr 2019 - Minutes_D_Website_final.pdf
AGM Information
2019-05-16 Dutch
6-K Filing
Foreign Filer Report
2019-05-06 English
Galapagos reports on historic first quarter 2019
Earnings Release Q1 2019
2019-04-26 English
Galapagos reports on historic first quarter 2019
Earnings Release Q1 2019
2019-04-26 English
6-K Filing
Foreign Filer Report
2019-04-26 English
Eerste kwartaalverslag 2019 FINAAL.pdf
Interim / Quarterly Report Q1 2019
2019-04-25 Dutch
GLPG Q119 NL FINAL.pdf
Earnings Release Q1 2019
2019-04-25 Dutch
Galapagos and MorphoSys announce initiation of GECKO Phase 2 study with MOR106 in atopic dermatitis patients
Regulatory Filings
2019-04-24 Dutch
Galapagos and MorphoSys announce initiation of GECKO Phase 2 study with MOR106 in atopic dermatitis patients
Regulatory Filings
2019-04-24 English
6-K Filing
Foreign Filer Report
2019-04-24 English
Galapagos creates new warrant plans
Capital/Financing Update
2019-04-11 Dutch
Galapagos creates new warrant plans
Capital/Financing Update
2019-04-11 English
6-K Filing
Foreign Filer Report
2019-04-11 English
Warrant Plan 2019 - 2019 RMV_ENG.pdf
Share Issue/Capital Change
2019-04-10 English
Warrant Plan 2019 - 2019 RMV_NL.pdf
Share Issue/Capital Change
2019-04-10 Dutch
EN report Deloitte_10 April 2019.pdf
Share Issue/Capital Change
2019-04-10 English
Warrant Plan 2019_BoD Report_596-598_D.pdf
Share Issue/Capital Change
2019-04-10 Dutch
Warrant Plan 2019_BoD Report_596-598_E.pdf
Capital/Financing Update
2019-04-10 English
NL report Deloitte_10 April 2019.pdf
Share Issue/Capital Change
2019-04-10 Dutch
Warrant Plan 2019_BoD Report_583_E.pdf
Remuneration Information
2019-04-10 English
Warrant Plan 2019_BoD Report_583_D.pdf
Remuneration Information
2019-04-10 Dutch
Publication of the annual report and invitation to the annual shareholders' meeting
AGM Information
2019-04-01 English
Publication of the annual report and invitation to the annual shareholders' meeting
Report Publication Announcement
2019-04-01 Dutch
6-K Filing
Foreign Filer Report
2019-04-01 English
glpg_jv18_29 maart 2019.pdf
Annual Report FY 2018
2019-03-29 Dutch
Publication AR and AGM Convening Notice_NL.pdf
Report Publication Announcement
2019-03-29 Dutch
8. Number of Shares and Voting Rights.pdf
Share Issue/Capital Change
2019-03-29 Dutch
7. Professional qualifications of Mr. Peter Guenter EN & NL.pdf
Board/Management Information
2019-03-29 English
6. Statutory auditor report - NL.pdf
Audit Report / Information FY 2018
2019-03-29 Dutch
6. Statutory auditor report - EN.pdf
Audit Report / Information FY 2018
2019-03-29 English
5. Non-consolidated financial statements.pdf
Annual Report FY 2018
2019-03-29 Dutch
glpg_ar18_FINAL 29 March 2019.pdf
Annual Report FY 2018
2019-03-29 English
3. Attendance Notification Form - EN & NL.pdf
AGM Information
2019-03-29 Dutch
Publication AR and AGM Convening Notice_EN.pdf
Report Publication Announcement
2019-03-29 English
2. Proxy Form - EN & NL.pdf
AGM Information
2019-03-29 Dutch
1. Convening Notice - EN.pdf
AGM Information
2019-03-29 English
1. Convening Notice - NL.pdf
AGM Information
2019-03-29 Dutch
glpg_ar18_FINAL 29 March 2019.pdf
Annual Report FY 2018
2019-03-29 English
glpg_jv18_29 maart 2019.pdf
Annual Report FY 2018
2019-03-29 Dutch
glpg_ar18_FINAL 29 March 2019.pdf
Annual Report FY 2018
2019-03-29 English
glpg_jv18_29 maart 2019.pdf
Annual Report FY 2018
2019-03-29 Dutch
GILEAD AND GALAPAGOS ANNOUNCE FILGOTINIB MEETS PRIMARY ENDPOINT IN THE PHASE 3 FINCH 3 STUDY IN METHOTREXATE-NAÏVE RHEUMATOID ARTHRITIS PATIENTS
Earnings Release Q1 2019
2019-03-29 Dutch
GILEAD AND GALAPAGOS ANNOUNCE FILGOTINIB MEETS PRIMARY ENDPOINT IN THE PHASE 3 FINCH 3 STUDY IN METHOTREXATE-NAÏVE RHEUMATOID ARTHRITIS PATIENTS
Regulatory Filings
2019-03-29 English
GILEAD AND GALAPAGOS REPORT UPDATED SAFETY INFORMATION FOR FILGOTINIB IN RHEUMATOID ARTHRITIS (RA)
Earnings Release Q1 2019
2019-03-29 Dutch
GILEAD AND GALAPAGOS REPORT UPDATED SAFETY INFORMATION FOR FILGOTINIB IN RHEUMATOID ARTHRITIS (RA)
Earnings Release Q1 2019
2019-03-29 English
20-F Filing
Annual Report FY 2018
2019-03-29 English
6-K Filing
Foreign Filer Report
2019-03-29 English
6-K Filing
Foreign Filer Report
2019-03-29 English
6-K Filing
Foreign Filer Report
2019-03-29 English
GILEAD AND GALAPAGOS REPORT UPDATED SAFETY INFORMATION FOR FILGOTINIB IN RHEUMATOID ARTHRITIS (RA)
Earnings Release Q1 2019
2019-03-28 English
GILEAD EN GALAPAGOS RAPPORTEREN MEEST RECENTE VEILIGHEIDSINFORMATIE VOOR FILGOTINIB IN REUMA
Earnings Release Q1 2019
2019-03-28 Dutch
GILEAD AND GALAPAGOS ANNOUNCE FILGOTINIB MEETS PRIMARY ENDPOINT IN THE PHASE 3 FINCH 3 STUDY IN METHOTREXATE-NAÏVE RHEUMATOID ARTHRITIS PATIENTS
Earnings Release Q1 2019
2019-03-28 English
GILEAD EN GALAPAGOS KONDIGEN AAN DAT FILGOTINIB HET BELANGRIJKSTE ONDERZOEKSDOEL HEEFT GEHAALD IN DE FASE 3 FINCH 3-STUDIE BIJ METHOTREXAAT-NAÏEVE REUMAPATIENTEN
Earnings Release Q1 2019
2019-03-28 Dutch
GILEAD AND GALAPAGOS ANNOUNCE FILGOTINIB MEETS PRIMARY AND KEY SECONDARY ENDPOINTS IN THE PHASE 3 FINCH 1 RHEUMATOID ARTHRITIS STUDY
Earnings Release Q1 2019
2019-03-28 English
GILEAD EN GALAPAGOS KONDIGEN AAN DAT FILGOTINIB DE
Earnings Release Q1 2019
2019-03-28 Dutch
Galapagos increases share capital through warrant exercises
Capital/Financing Update
2019-03-21 Dutch
Galapagos increases share capital through warrant exercises
Share Issue/Capital Change
2019-03-21 English
6-K Filing
Foreign Filer Report
2019-03-21 English
Share Capital Increase 20-Mar-2019 FINAL.pdf
Share Issue/Capital Change
2019-03-20 English
Share Capital Increase - 20-Mar-2019 - NL FINAL.pdf
Share Issue/Capital Change
2019-03-20 Dutch
Robuuste voortgang in de evolutie naar een geïntegreerd biofarmaceutisch bedrijf
Earnings Release FY 2018
2019-02-22 Dutch
Robuuste voortgang in de evolutie naar een geïntegreerd biofarmaceutisch bedrijf
Annual Report FY 2018
2019-02-22 Dutch
Firmly on our way to becoming a fully integrated biopharma company
Annual Report FY 2018
2019-02-22 English
Firmly on our way to becoming a fully integrated biopharma company
Earnings Release FY 2018
2019-02-22 English
FY2018_FINANCIAL-TABLES_NL.pdf
Annual Report FY 2018
2019-02-21 Dutch
FY2018_FINANCIAL-TABLES_EN.pdf
Annual Report FY 2018
2019-02-21 Dutch
FY2018_ENG_FINAL.docx.pdf
Earnings Release FY 2018
2019-02-21 English
FY2018_NL_FINAL.docx.pdf
Earnings Release FY 2018
2019-02-21 Dutch
SC 13G/A Filing
Major Shareholding Notification
2019-02-14 English
SC 13G Filing
Major Shareholding Notification
2019-02-12 English
Evotec and Galapagos enter into collaboration in the field of fibrosis/ Evotec en Galapagos gaan samenwerking aan in fibrose
M&A Activity
2019-02-07 Dutch
Evotec and Galapagos enter into collaboration in the field of fibrosis/ Evotec en Galapagos gaan samenwerking aan in fibrose
Regulatory Filings
2019-02-07 Dutch
6-K Filing
Foreign Filer Report
2019-02-07 English
SC 13G Filing
Major Shareholding Notification
2019-01-10 English
Sands Capital reports 5.7% holding in Galapagos
Major Shareholding Notification
2019-01-09 English
Sands Capital reports 5.7% holding in Galapagos
Major Shareholding Notification
2019-01-09 English
6-K Filing
Foreign Filer Report
2019-01-09 English
Sands_Transparency_ENG.pdf
Major Shareholding Notification
2019-01-08 English
Sands_Transparantie_NL.pdf
Major Shareholding Notification
2019-01-08 Dutch
Fibrocor and Galapagos sign partnership in fibrosis
Regulatory Filings
2019-01-07 English
Fibrocor and Galapagos sign partnership in fibrosis
M&A Activity
2019-01-07 English
Galapagos initiates NOVESA Phase 2a trial in patients with systemic sclerosis
Regulatory Filings
2019-01-07 English
Galapagos initiates NOVESA Phase 2a trial in patients with systemic sclerosis
Earnings Release Q1 2019
2019-01-07 English
Galapagos starts first Phase 1 trial with Toledo compound
Regulatory Filings
2019-01-07 English
6-K Filing
Foreign Filer Report
2019-01-07 English
6-K Filing
Foreign Filer Report
2019-01-07 English
6-K Filing
Foreign Filer Report
2019-01-07 English